AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

AbbVie announced a $1.4 billion investment to construct a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. This state-of-the-art facility will integrate advanced manufacturing and AI technologies to produce immunology, neuroscience, and oncology medicines, representing AbbVie’s largest capital investment to date. The project is expected to create 734 new jobs and over 2,000 construction jobs, strengthening AbbVie’s manufacturing capabilities and contributing to its $100 billion commitment to US R&D and capital investments.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin